Skip to main content

LHRH Antagonists with Low Histamine Releasing Activity

  • Chapter
LHRH and Its Analogs

Abstract

Many synthetic antagonists of LHRH having pituitary receptor binding affinities of 10 to 20 times that of LHRH itself have been made. Generally, the best antagonists have an ED50 of about one microgram per animal in the rat antiovulatory assay. Most of these highly effective antagonists have a D-arginine residue in position 6 which, with the L-arginine8 of the native molecule and with a hydrophobic cluster of residues in the N-terminal part of the molecule, appears to be a potent canbination for the release of histamine from mast cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Schmidt, F., Sundaram, K., Thau, R.B. and Bardin, C. W. [Ac-D-Nal (2)1, 4F-D-Phe2, D-Trp3, D-Arg6]-LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in rats. Contraception, 29, 283 (1984).

    Article  PubMed  CAS  Google Scholar 

  2. Theoharides, T.C. and Douglas, W.W. Mast cell histamine secretion in response to somatostatin analogues: structural considerations. Eur. J. Pharmacol., 73, 131 (1981).

    Article  PubMed  CAS  Google Scholar 

  3. Roeske, R.W., Chaturvedi, N., Rivier, J., Vale, W., Porter, J. and Perrin, M. Substitution of Arg5 for Tyr5 in GhRH antagonists. In: “Peptides: Structure and Function.” C.M. Deber, V.J. Hruby and K.D. Kopple (Eds.), Pierce Chemical Co., Rockford, IL, 1985, p. 561.

    Google Scholar 

  4. Momany, F.A. Conformational energy analysis of the molecule, luteinizing hormone-releasing hormone. 1. Native decapeptide. J. Am. Chem. Soc., 98, 2990 (1976).

    Article  PubMed  CAS  Google Scholar 

  5. Freidinger, R.M., Veber, D.F., Perlow, D.S., Brooks, J.R. and Saperstein, R. Bioactive conformation of luteinizing hormone-releasing hormone: Evidence from a conformationally constrained analog. Science, 210, 656 (1980).

    Article  PubMed  CAS  Google Scholar 

  6. Nestor, J.J., Jr., Ho, T.L., Tahilramani, R., McRae, G.E. and Vickery, B.H. Long-acting LHRH agonists and antagonists. In: “LHRH and Its Analogues,” F. Labrie, A. Belanger, A. Dupont (Eds). Elsevier, Amsterdam, 1984, p. 24.

    Google Scholar 

  7. Nestor, J.J., Jr., Ho, T.L., Tahilramani, R., Horner, B.L., Simpson, R. A., Jones, G.H., McRae, G.I. and Vickery, B.H. LHRH agonists and antagonists containing very hydrophobic amino acids. In: “LHRH and Its Analogs: Contraceptive and Therapeutic Applications,” B.H. Vickery, J.J. Nestor, Jr. and E.S.E. Hafez (Eds.), MTP Press, Boston, 1984, p. 23.

    Chapter  Google Scholar 

  8. Rivier, J.E., Porter, J., Rivier, C.L., Perrin, M., Corrigan, A., Hook, W.A., Siraganian, R.P. and Vale, W.W. New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro. J. Med. Chem., 29, 1846 (1986).

    Article  PubMed  CAS  Google Scholar 

  9. Folkers, K., Bowers, C., Shaobo, X., Tang, P. and Kubota, M. Increased potency of antagonists of the luteinizing hormone releasing hormone which have D-3-Pal in position 6. Biochem. Biophys. Res. Comm., 137, 709 (1986).

    Article  PubMed  CAS  Google Scholar 

  10. Prasad, K.U., Roeske, R. W., Weitl, F. L., Vilchez-Martinez, J.H. and Schally, A.V. Structure-activity relationships in luteinizing hormone-releasing hormone. J. Med. Chem., 19, 492 (1976).

    Article  PubMed  CAS  Google Scholar 

  11. Jasani, B., Kreil, G., Mackler, B.F. and Stanworth, D.R. Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells. Biochem. J. 181, 623 (1979).

    PubMed  CAS  Google Scholar 

  12. Stanworth, D.R., Kings, M., Roy, P., Moran, J. and Moran, D. Synthetic peptides comprising sequences of the human immunoglobulin E heavy chain capable of releasing histamine. Biochem. J., 180, 665 (1979).

    PubMed  CAS  Google Scholar 

  13. Corbin, A. and Beattie, C.W. Inhibition of the pre-ovulatory proestrous gonadotropin surge, ovulation and pregnancy with a peptide analogue of luteinizing hormone releasing hormone. Endocr. Res. Commun., 2, 1 (1975).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

B. H. Vickery J. J. Nestor Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 1987 MTP Press Limited

About this chapter

Cite this chapter

Roeske, R.W., Chaturvedi, N.C., Hrinyo-Pavlina, T., Kowalczuk, M. (1987). LHRH Antagonists with Low Histamine Releasing Activity. In: Vickery, B.H., Nestor, J.J. (eds) LHRH and Its Analogs. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3229-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-3229-6_2

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7949-5

  • Online ISBN: 978-94-009-3229-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics